Corus Pharma's Series B Round

Corus Pharma raised a round of funding on March 06, 2003.

Corus Pharma, Inc. was acquired by Gilead Sciences in August 2006. Prior to the acquisition, Corus was developing small molecule drugs for the treatment of respiratory diseases.…

Articles about Corus Pharma's Series B Round: